Patients should increase blood glucose monitoring frequency, particularly during the first few weeks after initiating or adjusting either medication
In 2017, when the FDA approved weekly shots for diabetes, and again in 2021, when the drug was popularized as a weight-loss treatment and patients started asking for Wegovy, Cepbound and Ozempic
Oral semaglutide, marketed as Rybelsus, presents differently as it comes in tablet form
Indeed, if tirzepatide and other GLP-1 drugs for weight loss become subject to mandatory discounting through the Inflation Reduction Act (by 2031, or sooner if their developers attempt to reduce prices in anticipation of this deadline) or similar regulation, their prices would be directly reduced, making them more affordable
Clinicians can see multiple patients in a single location, which reduces overhead and keeps costs lower for each session
& McKee, P